Introduction Thr) (sTn) (Kjeldsen et al., 1988) . Recent experiments have demonstrated that the minimal epitope for the B72.3 antibody Immunoglobulin G molecules consist of pairs of associated is the dimeric sTn-serine cluster (sTn 2 ) (Reddish et al., heavy (H) and light (L) polypeptide chains, each of which 1997). The B72.3 antibody has been extensively employed for contains multiple globular domains. All of these domains immunodetection of human malignancies, revealing a 70-80% exhibit a similar folding pattern, often described as a sandwich positive rate including 20% occult lesions (Carrasquillo et al. , of three and four stranded antiparallel β-sheets that are linked 1988; Percivale et al., 1996) . However, the molecular basis of by disulfide bonds. Sequence comparisons between H-and Lthe recognition by B72.3 combining sites is not well underchain variable (V) domains reveal that each domain has three stood. Structural details would, of course, improve our knowcomplementarity-determining regions (CDRs) flanked by four ledge of the molecular basis of antigen recognition by B72.3. framework regions (FRs) of less variable sequence (Kabat In an analogous situation, the X-ray structure of an anti-tumor et al., 1991) . Antibody combining sites are formed by the antibody in complex with carbohydrate antigen provided a juxtaposition of six CDRs appearing as loops at one end of a rationale for mutagenesis experiments that have resulted in β-sheet barrel, three loops from V H and another three from CDR loop mutants with increased affinity for nLe v antigen V L . These CDR loops form a surface that interacts with an and tumor cells (Jeffrey et al., 1995) . The crystal structure for antigen. Note that only a subset of the presented CDR residues the B72.3 FabЈ revealing some important structural features makes contact with an antigen (Wilson and Stanfield, 1993) . of B72.3 combining sites has been determining and refined to Not surprisingly, amino acid substitutions at these contact CDR residues can significantly alter both the antibody specifia resolution of 3.1 Å with an R-factor of 17.6% (Brady et al., 1991) . However, at present, no structural data on the B72.3/ TAG72 complex are available. In this study, we developed a computational model of B72.3/ sTn 2 complex and identified 17 contact CDR residues based upon this complex model. The modeling study helped us to plan a mutagenesis strategy for conducting site-directed mutagenesis at predicted contact CDR residues. The binding affinities of these mutant antibodies were measured in a solidphase radioimmunoassay (RIA) and compared with that of the original antibody cB72.3 (Xiang et al., 1990) .
Materials and methods

Cell lines and antigen
The SP2/0Ag14 melanoma cell lines that lack the expression of internal H-and L-chains of myeloma protein were purchased from the American Type Culture Collection (ATCC, Rockville, MD). The transfectoma cell line (Xiang et al., 1990) , which secretes a mouse/human chimeric anti-TAG72 antibody cB72.3, was maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS) and geneticin (0.5 mg/ml). Bovine submaxillary gland mucin (BSM) (Sigma Chemical, St. Louis, MO), which contains the TAG72 epitope (Xiang et al., 1990) , was used as the antigen source in this study.
Molecular modeling
The previously determined structure of the B72.3 FabЈ fragment (Brady et al., 1992) was used as a template. The 3-D structure single sTn was built from two galactosamine moieties via a 2-6 alpha connection, with serine and sialic acid linked at the sequentially and according to Kabat's method (Kabat et al., two ends. In the light of the U-shaped binding channel of the 1991) (Figure 1 ). CDR loops L1, L2 and L3 adopt a canonical epitope (see Results and Discussion), a preliminary model of structure of types 2, 1 and 1, while CDR loops H1 and H2 the double sTn molecule was then readily constructed by belong to types 1 and 2, respectively (Chothia et al., 1989) . joining two single sTn moieties together which would be further optimized in later energy minimization calculations.
As observed from the modeled B72.3/sTn 2 complex, 17 CDR It was known from our earlier site-directed mutagenesis contact residues are thought to have hydrogen bonds and van experiments that residues Asp55, Ser95 and Tyr97 in the Hder Waals interactions with the sTn 2 epitope, including 11 Hchain and Tyr96 in the L-chain appeared to affect sTn epitope chain CDR residues (His32, Ala33, His35, Tyr50, Ser52, binding (Xiang et al., 1996) . Taking this into consideration, Asn54, Asp56, Lys58, Ser95, Tyr96 and Tyr97) and six Lthe initial docking position of a single sTn epitope with respect chain CDR residues (Asn32, Phe91, Trp92, Gly93, Thr94 and to the B72.3 Fab was determined using the program DOCK Tyr96). Among them, epitope interactions with two H-chain (Kuntz, 1992) . The epitope was treated as a rigid body in the contact CDR residues (Ser95 and Tyr97) and one L-chain first round of docking, but all atoms were allowed to move contact CDR residue (Tyr96) have been previously demonindividually in subsequent rounds of optimization. Following strated by site-directed mutagenesis (Xiang et al., 1996) . Of the positioning of the single sTn, the double sTn (sTn 2 ) epitope the remaining 14 residues found to interact with sTn 2 in our was manually placed in the binding pocket of B72.3 Fab. The model, two L-chain CDR residues (Phe91 and Gly93) have complex model was subjected to Powell energy minimization interactions with the sTn 2 epitope through their main-chain implemented in X-PLOR (Brünger, 1992) , where 2000 cycles atoms. It is possible that mutations of these two residues might of energy minimization was carried out and energy converged.
introduce some steric effects that may interfere with mainThe parameter file used in the energy minimization was chain interactions, although it is expected to be unlikely since compiled and modified using the similar parameter files for the side chains in question point away from the sTn 2 epitope. serine, sialic acid and glucosamine fragments, available at the Consequently, these sites were not selected for alteration by website http://xplor.csb.yale.edu/hetero. Note that glucosamine mutation, thus avoiding any compliction in our results. To differs from galactosamine in only the orientation of a single examine whether the remaining 12 CDR residues influence hydroxyl group and the parameter file was readily converted.
the binding affinity for the TAG72 antigen, these CDR residues All graphics analysis was carried out on SGI graphics comwere individually changed by site-directed mutagenesis either puters.
to eliminate hydrogen bonds or to alter van der Waals interSite-directed mutagenesis actions at these positions. Twelve oligonucleotides (oligo 1-12) complementary to different areas of V H and V K regions Amino acid sequences of the previously cloned cB72.3 V H and V K genes (Xiang et al., 1990 (Xiang et al., , 1992 ) are numbered of the cB72.3 (Xiang et al., 1990 (Xiang et al., , 1992 were designed and synthesized for amino acid substitutions. These 12 oligonucleoantibodies cB72.3m1-12 were further purified from their supernatants by Protein A-Sepharose column chromatography tides includes oligo 1 (5Јcttca ctgac GCtgc tattc ac 3Ј), oligo 2 (5Ј cactg accat CTtat tcact gg 3Ј), oligo 3 (5Јccatg ctatt (Xiang et al., 1990) . Protein concentrations were determined using a Bio-Rad protein assay kit (Bio-Rad, Sunnyvale, CA) GCctg ggcga ag 3Ј), oligo 4 (5Јatgga ttgga GCtat ttctc cc3Ј), oligo 5 (5Јtggat atatt Gctcc cggaa at 3Ј), oligo 6 (5Јttctc ccgga according to the manufacturer's instructions. GCtga tgata tt 3Ј), oligo 7 (5Јtgatg atatt GCgta caatg ag 3Ј), Affinity constants oligo 8 (5Јtaaaa gatcg GCcta cggcc ac 3Ј), oligo 9 (5Јtgatg The affinity constants of the original cB72.3 antibody and the atatt GCgta caatg ag 3Ј), oligo 10 (5Јtattt acagt GCttt agcat mutant cB72.3m1-12 antibodies were determined in a solidgg 3Ј), oligo 11 (5Јtcaac atttt GCggg tactc cg 3Ј) and oligo 12 phase RIA as described previously (Xiang et al., 1996) . Briefly, (5Јtttt gggt Gctcc gtaca gt 3Ј). Note the mutated nucleotides are serial dilutions of mutant antibodies were added to each mucincapitalized. These mutations include nine H-chain mutations coated well (in triplicate) of the first microtiter plate for (His32Ala, Ala33Leu, His35Ala, Tyr50Ala, Ser52Ala, incubation overnight at 4°C. The supernatants of each well, Asn54Ala, Asp56Ala, Lys58Ala and Tyr96Ala) and three Lwhich contain the free mutant antobodies, were transferred to chain mutations (Asn32Ala, Trp92Ala and Thr94Ala).
each well of the second microtiter plate that had previously Mutations were introduced into M13mp1-V H or M13mp19-V K been coated with goat anti-human IgG antibody. The amounts by these 12 oligonucleotides through site-directed mutagenesis of bound and free antibodies in the first and the second plates (Zoller and Smith, 1983) to form 12 plasmids (M13mp19-were measured by using the 125 I-labeled goat anti-human IgC V Hm1-9 and M13mp19-V Km1-3 ), each containing a mutant antibody. Scatchard plot analysis was carried out to calculate B72.3 V H or V K region of cDNA fragment with the RNA the affinity constants (K a ) (Scatchard, 1949) . The ratios of the splice junction consensus sequence (5Јcaggtagt 3Ј) at its 3Ј concentration of bound to free antibody were plotted against end (Xiang et al., 1990 (Xiang et al., , 1992 . Sequences of these mutant the concentration of bound antibody. The slope represents K a V Hm1-9 and V Km1-3 regions were verified by the dideoxy of each mutant antibody. nucleotide sequencing method (Sanger et al., 1977) .
Construction of expression vectors
Results and discussion The mutant V Hm1-9 cDNA fragments (EcoRI/SalI) were purified
Modeling of the B72.3/TAG72 complex from M13mp19-V Hm1-9 by EcoRI/SalI digestion and introduced
The single sTn complex model is unable to satisfy all experiinto an EcoRI/XhoI site in the multiple cloning region of mentally characterized interactions involving residues Ser95 mpSV2neo-EP1-C γ1 (Xiang et al., 1990) to form the chimeric and Tyr97 in the H-chain and Tyr96 in the L-chain (Xiang H-chain expression vectors mpSV2neo-EP1-V Hm1-9 . The et al., 1996) . Some, but not all, of the experimentally confirmed mutant V Km1-3 cDNA fragments (SalI) were purified from the contact residues are able to interact simultaneously with the M13mp19-V Km1-3 by SalI digestion and introduced into a SalI single sTn epitope. However, the single sTn model provides site in the multiple cloning region of mpSV2gpt-EP1-C K an important clue as to how the shape complementarity between (Xiang et al., 1992) to form the chimeric L-chain expression antibody and antigen can be maximized by the judicious vector mpSV2gpt-EP1-V Km1-3 -C K . The ligated chimeric H-or placement of residues known to interact with the antigen. The L-chain expression vectors containind either the neo gene for binding cavity resembles a U-shaped channel centered near geneticin selection or the gpt gene for mycophenolic acid Tyr96. The size and overall shape of the binding cavity suggest selection, and a complete transcription unit including enhancer that sTn 2 , not sTn, may in fact be the preferred epitope. Our (E), immunoglobulin promoter (P1), mutant V Hm1-9 or V subsequent modeling studies indicate that the sTn 2 epitope region cDNA fragments and human genomic γ1 (C γ1 ) or K possesses a high degree of structural and chemical compleconstant region (C K ). These 12 expression vectors mpSV2neo-mentarity with the binding site. Also, the interactions observed EP1-V Hm1-9 C γ1 and mpSV2gpt-EP1-V Km1-3 C K were used for in such a complex are consistent with all of the experimental the expression of 12 mutant chimeric cB72.3m1-12 antibodies mutagenesis data obtained previously (Xiang et al., 1996) . (Xiang et al., 1990 (Xiang et al., , 1992 .
The model is also supported by some recently reported Expression of mutant chimeric antibodies experimental evidence (Reddish et al., 1997) , in which the binding of B72.3 antibody to the TAG72 antigen has been The chimeric H-and L-chain expression vector DNAs of mpSV2neo-EP1-V Hm1-9 C γ1 and mpSV2gpt-EP1-V Km1-3 C K were shown to be inhibited by the sTn 2 epitope, but not by sTn. Based on the sTn 2 complex model, we analyzed various transfected into the SP2/0Ag14 cells by electroporation as described previously (Xiang et al., 1990 (Xiang et al., , 1992 . Cells were interactions between the B72.3 Fab and the sTn 2 epitope. In this model, numerous polar atoms are at appropriate geometries selected for growth in media containing either geneticin at 2.0 mg/ml or mycophenolic acid at 25 µg/ml. After 14 days, to form hydrogen bonds, and contact distances between B72.3 Fab and sTn 2 suggest that many less specific van der Waals growth supernatants were screened in human γ-and K-chain capture ELISA for examining the expression of chimeric interactions should form. Table I summarizes all potential interactions between the B72.3 antibody and the sTn 2 epitope, cB72.3m1-9 antibodies and the mutant chimeric L-chains (K m1-3 ) respectively (Xiang et al., 1990 (Xiang et al., , 1992 . The positive as identified from the complex model. As seen from Table I , a total of 17 CDR contact residues are predicted to interact clones derived from the SP2/0Ag14 cell line for the expression of mutant chimeric L-chains were further transfected with the with the sTn 2 epitope by way of either hydrogen bonds or van der Waals interactions. These include nine H-chain CDR chimeric H-chain expression vector DNA mpSV2neo-EP1-V H C γ1 (Xiang et al., 1990) and selected for growth in media residues (His32, His35, Tyr50, Ser52, Asn54, Asp56, Ser95, Tyr96 and Tyr97) and four L-chain CDR residues (Asn32, containing both geneticin (2 mg/ml) and mycophenolic acid (25 µg/ml). The growth supernatants were then screened in Phe91, Gly93 and Tyr96) having both hydrogen bonds and van der Waals interactions with the sTn 2 ligand, and two Hhuman γ-chain capture ELISA for examining the expression of mutant chimeric antibodies cB72.3m10-12. Mutant chimeric chain CDR residues (Ala33 and Lys58) and two L-chain c Three contact CDR residues including two heavy-chain residues (Ser95 and Tyr97) and one light-chain residue (Tyr96) were previously confirmed by site-directed mutagenesis (Xiang et al., 1996) . d Two light-chain contact CDR residues (Phe91 and Gly93) have atomic interactions with the sTn 2 epitope through their main chains.
CDR residues (Trp92 and Thr94) having only van der Waals Site-directed mutagenesis and affinity constant of mutant antibodies Among these 17 contact CDR residues, two H-chain CDR residues (Ser95 and Tyr97) and one L-chain CDR residue (Tyr96) have been previously demonstrated by site-directed mutagenesis to be involved in epitope contact (Xiang et al., 1996) . Amino acid substitution at these positions resulted in a significantly decreased affinity towards the TAG72 antigen. In addition, our previous studies have also shown that some atomic interactions that form between CDR and FR residues may play an important role in influencing TAG72 binding by altering CDR loop conformations (Xiang et al., 1995 (Xiang et al., , 1999 . Site-directed mutagenesis was performed at 12 positions, nine in H-chain (His32, Ala33, His35, Tyr50, Ser52, Asn54, Asp56, Lys58 and Tyr96) and three in L-chain (Asn32, Trp92 and Thr94). All positions except for Ala33 were subjected to mutagenesis by alanine scanning, which is a useful tool for the identification of functionally important side chains (Jin and Wells, 1994) . Because the short side chain of Ala33 has of Ala33 to Leu, a residue with a larger side chain, was illustrated (last letter following the residue number, H or L, stands for designed to generate steric clash with the epitope. Site-directed heavy-or light-chain). This diagram was prepared using Grasp (Nicholls et al., 1993) . mutagenesis resulted in the generation of 12 mutant chimeric antibodies cB72.3m1-12. The affinity constants of these 12 mutant antibodies for the TAG72 antigen were determined in eight mutant antibodies (cB72.3m1-2 and cB72.3m4-9). Four mutant antibodies (cB72.3m3 and cB72.3m10-12) had the a solid-phase RIA. As shown in Table 2 , the affinity reduction of mutant antibodies, which ranged from 8-to 84-fold compared same affinity constant for the TAG72 antigen as the original cB72.3 antibody. with that of the original cB72.3 antibody, was found in Figure 3 . Hydrogen bonds are highlighted by dashed lines and distances (in Å). This diagram was prepared using Molscript (Kraulis, 1991). suggesting that Tyr 96 plays a critical role in antigen binding, reported Tyr96Phe mutation (Xiang et al., 1996) , which had cB72.3ml His by Ala (H32) 52 no effect on sTn 2 binding, it seems to suggest that the hydroxyl in these mutants is not wholly incompatible with our model.
to the TAG72 antigen in the solid-phase radioimmunoassay.
Similarly, the mutation at L-chain residue Thr94, which also b The affinity constant (K a ) of the cB72.3 antibody for the TAG72 antigen was 8.2 ϫ 10 8 M -1 as measured in the solid-phase radioimmunoassay. The had no effect on activity, probably reflects the fact that affinity reduction of each mutant antibody was calculated by dividing the K a there are no hydrogen bonds and only weak van der Waals of the cB72.3 antibody by that of the individual mutant antibody.
interactions between this residue and the sTn 2 epitope. Surprisingly, however, is the fact that the H-chain mutation His35Ala Correlation between model prediction and experimental did not affect the affinity of mutant antibody cB72.3m3 for results the TAG72 antigen. This has been difficult to rationalize since The sTn 2 complex, modeled using limited knowledge of contact His35 would be involved in both H-bonding and van der residues at the initial stage of this study, predicted that 12 Waals interaction. It may be a reflection of the limitations of additional residues interact with the sTn 2 epitope through their the modeling and its accuracy in predicting contact residues. side chains. Our later mutagenesis experiments confirmed this Interestingly, in our previous experiments, we have shown that assumption that most of these predictions are correct with only the mutation of His35Leu did not affect the TAG72 binding four exceptions including one H-chain mutation of His35Ala (Xiang et al., 1996) . The inconsistency, and perhaps some of and three L-chain mutations of Asn32Ala, Trp92Ala and the others mentioned above, might also be explained by the Thr94Ala. The majority of these predicted residues have concept of 'functional epitope of the antibody', in which only hydrogen bonding (Figure 4 ) and/or van der Waals interactions some of the contact residues observed by X-ray crystallography with the sTn 2 ligand. In cases where the amino acid was are found to dominate the energetics of antigen binding (Davies changed to Ala, the shortened side-chain would be unable Kelley and O'Connell, 1993) . interact with the antigen, causing a decrease in binding affinity.
Our previous study showed that a single amino acid substituIn the case of Ala33, it was predicted that van der Waals tion at three H-chain CDR residues (Asp55, Ser95 and Tyr97) interactions could occur between the antigen and the side chain and at one L-chain CDR residue (Tyr96) resulted in affinity of Ala33; any bulkier replacement should cause steric clash.
reductions of 20-, 8-, 15-and 40-fold, respectively (Xiang Upon changing to Leu, the binding affinity of the epitope did et al., 1996) . These results are consistent with what is predicted indeed decrease drastically (84-fold), supporting our model's from our complex model. Three of these four residues are prediction. Of all of the mutants, Tyr96, is a particularly found in contact with sTn 2 in our computational model. The interesting residue because it is strategically positioned in the fourth residue in this group, Asp55, while not in direct contact middle of the 'U'-shaped sTn 2 binding channel (Figure 3) .
with the sTn 2 epitope, does nevertheless have potential to affect epitope binding. It can form a strong salt bridge with Binding was weaked by the Tyr→Ala mutation by 40-fold,
